These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3054462)

  • 21. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
    Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
    Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insulin therapy with pens and pumps].
    Schwedes U
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():16. PubMed ID: 8839106
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of glibenclamide in insulin-treated diabetic patients with a residual insulin secretion.
    Mauerhoff T; Ketelslegers JM; Lambert AE
    Diabete Metab; 1986 Feb; 12(1):34-8. PubMed ID: 3084315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with human proinsulin in eighteen patients with type I and type II diabetes mellitus.
    Thomas VA; Lamberton RP; Krauss DS; Kahn CB
    R I Med J (1976); 1991 Oct; 74(10):463-8. PubMed ID: 1957115
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical examination of diabetic patients treated with monocomponent insulin manufactured by MP Polfa].
    Orłowska-Kunikowska E; Horoszek-Maziarz S; Loss-Fisior R; Semetkowska-Jurkiewicz E; Dominiak K; Wójcikowski C
    Pol Tyg Lek; 1989 May 22-29; 44(21-22):503-6. PubMed ID: 2702341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of semisynthetic human insulins in diabetes mellitus].
    Nedosugova LV; Balabolkin MI; Tsaguriia KG
    Sov Med; 1991; (10):75-8. PubMed ID: 1801244
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of hypoglycemic therapy on atherogenesis in diabetic patients].
    Tuev AV; Smirnova EN
    Klin Med (Mosk); 1992 Jan; 70(1):57-9. PubMed ID: 1608214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The absorption of short-acting insulin administered subcutaneously in diabetic patients].
    Nakamura T; Sekino K; Kasai F; Ishii F; Kudoo M; Imamura K; Kikuchi N; Takebe K
    Probl Endokrinol (Mosk); 1993; 39(2):14-6. PubMed ID: 8016042
    [No Abstract]   [Full Text] [Related]  

  • 29. [ Change of insulin U40 to insulin U100: comparison of blood insulin and blood sugar in the diabetic patient].
    Scheen AJ; Guiot J; Stassen MP; Jandrain B; Paquot N; Lefèbvre PJ
    Rev Med Liege; 1991 Apr; 46(4):181-7. PubMed ID: 2052811
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of patients with acute intestinal obstruction in diabetes mellitus].
    Duboshina TB; Temnikov AI; Fedorov VE
    Vestn Khir Im I I Grek; 1989 Sep; 143(9):120-1. PubMed ID: 2694573
    [No Abstract]   [Full Text] [Related]  

  • 31. U. of A. grand rounds: The insulin-dependent diabetic patient. (unstable diabetes mellitus).
    Bressler R
    Ariz Med; 1977 Nov; 34(11):774. PubMed ID: 921556
    [No Abstract]   [Full Text] [Related]  

  • 32. A patient requiring 1,000 units of insulin per day!
    Raal FJ; Pieterse A
    S Afr Med J; 2000 Apr; 90(4):357-8. PubMed ID: 10957917
    [No Abstract]   [Full Text] [Related]  

  • 33. Insulin regulation for the diabetic patient on peritoneal dialysis.
    Stoddard PD; Gallagher NM
    Nephrol Nurse; 1979; 1(6):16-9. PubMed ID: 395452
    [No Abstract]   [Full Text] [Related]  

  • 34. [How do I control my insulin-dependent diabetes].
    Kähler C
    Ugeskr Laeger; 1990 Feb; 152(7):488-9. PubMed ID: 2408217
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of highly purified insulin on dosage requirements.
    Daggett P; Mustaffa BE; Nabarro JD
    Practitioner; 1977 Apr; 218(1306):563-8. PubMed ID: 323840
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined sulfonylurea and insulin therapy in insulin-dependent diabetes: research or clinical practice?
    Rizza RA
    Diabetes Care; 1985; 8(5):511-4. PubMed ID: 3902424
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intensive insulin therapy].
    Takaike H; Uchigata Y
    Nihon Rinsho; 2012 May; 70 Suppl 3():664-8. PubMed ID: 22768595
    [No Abstract]   [Full Text] [Related]  

  • 38. SMS 201-995 improves glucose tolerance in insulin-treated type II diabetic patients.
    Candrina R; Coppini A; Graffeo M; Zuccato F; Giustina G
    Diabetes Care; 1987; 10(4):534-5. PubMed ID: 2887407
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of the bronchospasmolytic agent Repreterol on the blood glucose level in diabetics].
    Tabori D; Conkić B; Aurich R
    Med Welt; 1979 Apr; 30(14):531-4. PubMed ID: 372730
    [No Abstract]   [Full Text] [Related]  

  • 40. [Quality of life of diabetic patients with intensified insulin therapy].
    Rose M; Schirop T; Klapp BF
    Versicherungsmedizin; 1997 Feb; 49(1):9-13. PubMed ID: 9133033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.